Related Experiment Video
Updated: Jun 6, 2026
10:03
Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
Published on: November 18, 2022
Type 1 diabetes vaccine development: animal models vs. humans
Tobias Boettler1, Matthias von Herrath
1La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA.
Human Vaccines
|December 16, 2010
Summary
Type 1 diabetes involves immune system attacks on pancreatic beta cells. Research explores microbial interactions and vaccine development to prevent or reverse this autoimmune response, potentially offering new therapies.
Area of Science:
- Immunology
- Endocrinology
- Microbiology
Background:
- Type 1 diabetes (T1D) is characterized by autoimmune destruction of pancreatic beta cells, leading to loss of glycemic control and complications.
- The interplay between microbial agents and the immune system is implicated in the development of autoimmune reactivity, potentially triggering T1D.
- Current T1D treatments often rely on general immunosuppression, highlighting the need for targeted therapies.
Purpose of the Study:
- To discuss recent advancements in vaccine discovery for type 1 diabetes.
- To explore the translation of findings from animal models to potential human therapies for T1D.
- To investigate strategies for preventing or reversing autoimmune responses in T1D.
Main Methods:
- Review of recent developments in vaccine discovery for autoimmune diseases.
- Analysis of data from animal models of type 1 diabetes.
- Discussion on the potential translation of preclinical findings to clinical applications in humans.
Main Results:
- The abstract does not detail specific experimental results but focuses on the discussion of research directions.
- Highlights the potential role of microbial agents in modulating autoimmune responses relevant to T1D.
- Emphasizes the need to bridge the gap between animal model findings and human therapeutic strategies.
Conclusions:
- Vaccine development holds promise for preventing autoreactivity or restoring immune regulation in type 1 diabetes.
- Translating findings from animal models is crucial for developing effective human T1D therapies.
- Further research is needed to develop safe and effective T1D vaccines that avoid general immunosuppression.
Related Concept Videos
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
02:43Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...